Sunday 28 February 2021
Home      All news      Contact us      RSS     
healtheuropa - 27 days ago

Single-dose Janssen COVID-19 vaccine shows 66% effectiveness

New data from the Phase III studies of Janssen’s single-dose COVID-19 vaccine candidate has shown 66% effectiveness in preventing coronavirus in participants. The UK has already secured 30 million doses of the Janssen COVID-19 vaccine which did not show any significant safety concerns and no serious adverse events in participants in the studies. Deliveries are [ ] The post Single-dose Janssen COVID-19 vaccine shows 66% effectiveness appeared first on Health Europa.


Latest News
Hashtags:   

Single

 | 

Janssen

 | 

COVID

 | 

vaccine

 | 

shows

 | 

effectiveness

 | 

Sources